---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-103773"
form_type: "8-K"
ticker: "TRAW"
cik: "0001130598"
company_name: "Traws Pharma, Inc."
filed_at: "2024-09-27T23:59:59+00:00"
generated_at: "2026-05-31T01:04:28.117920+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Traws Pharma receives Nasdaq delisting notice; will request hearing to regain compliance

## Summary
- Received delisting determination from Nasdaq on Sept 24, 2024 for failing to maintain minimum $1 bid price.
- Second compliance period ended Sept 23, 2024; company did not regain compliance despite extension.
- Company intends to request a hearing before Nasdaq Hearings Panel by Oct 1, 2024 to stay delisting.
- Stock currently trades above $1, but no assurance of regaining compliance or meeting other listing criteria.

## SEC filing metadata
- accession: 0001104659-24-103773
- form_type: 8-K
- ticker: TRAW
- cik: 0001130598
- company_name: Traws Pharma, Inc.
- filed_at: 2024-09-27T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130598/000110465924103773/0001104659-24-103773-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130598/000110465924103773/tm2425081d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-103773
- JSON: https://secwatch.observer/filing/0001104659-24-103773.json
- Plain text: https://secwatch.observer/filing/0001104659-24-103773.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.